Aurora Spine Issued 2nd Patent for DEXA Technology ORTHOFLASH Spine The patent pertains to body density scan result-matched orthopedic implants and methods of use for dexa patient-matched implant technology. Feb 05, 2024
Paragon 28 Introduces PRECISION MIS Bunion System ORTHOFLASH Trauma PRECISION MIS allows surgeons to complete a distal metatarsal osteotomy using a minimally invasive surgical technique. Feb 01, 2024
restor3d Launching New Foot & Ankle Offerings Joint Replacement ORTHOFLASH The company is introducing the Kinos Axiom X-Stem Tall Total Ankle and the Patient-Specific Total Talus. Feb 01, 2024
Ossium and Extremity Medical Partner on OssiGraft Viable Bone Matrix Company Updates Competitive Landscape The venture combines Ossium’s cellular therapeutics with Extremity Medical's robust network of orthopedic surgeons, hospitals and ASCs. Feb 01, 2024
IlluminOss Granted FDA Clearance for Light-Emitting Diode Console ORTHOFLASH Trauma By providing structural strength to fractured or weakened bone, IlluminOss implants may provide an opportunity for early mobility. Feb 01, 2024
Intelivation Technologies Launches Hammerdesis Interphalangeal Fusion ORTHOFLASH Trauma Hammerdesis allows surgeons to correct interphalangeal deformities by affixing a ring on the patient's toe joint. Feb 01, 2024
Phase I/II Clinical Trials for Theradaptive OsteoAdapt SP Orthobiologics ORTHOFLASH Theradaptive gained FDA approval for their IDE submission to enroll patients into OASIS, a global Phase I/II Feasibility study in spine fusion. Feb 01, 2024
Stryker Expands Prophecy Surgical Planning System with Footprint ORTHOFLASH Robotics/Tech Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offers comprehensive surgical planning across the entire foot. Jan 31, 2024
Paragon 28 Debuts FJ2000 Power Console and Burr System ORTHOFLASH Trauma FJ2000 offers single-use handpieces and a substantial selection of burrs and instruments in a sterile packed kit prepared for immediate use. Jan 31, 2024
Synergy Spine Closes $30 Million Financing Investments The Numbers Funds will support clinical trials, regulatory filing and ex-U.S. commercialization of the company's artificial cervical disc. Jan 31, 2024